Truepoint, Inc. Pfizer Inc Transaction History

Truepoint, Inc.

$3.45 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $22,184 - $28,815	-849 Reduced 9.74%	7,865 $226,000
Q3 2023 Nov 09, 2023	BUY	$32.09 - $37.51 $32,635 - $38,147	1,017 Added 13.21%	8,714 $289,000
Q2 2023 Aug 08, 2023	BUY	$36.12 - $41.79 $78,777 - $91,143	2,181 Added 39.54%	7,697 $282,000
Q1 2023 May 08, 2023	SELL	$39.39 - $51.28 $38,838 - $50,562	-986 Reduced 15.16%	5,516 $225,000
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $2,546 - $3,324	61 Added 0.95%	6,502 $333,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $132,942 - $162,289	-3,038 Reduced 32.05%	6,441 $282,000
Q2 2022 Aug 08, 2022	BUY	$46.53 - $55.17 $124,048 - $147,083	2,666 Added 39.13%	9,479 $497,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $105,545 - $130,783	2,307 Added 51.2%	6,813 $353,000
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $186,187 - $275,992	4,506 New	4,506 $266,000
Q3 2021 Oct 28, 2021	SELL	$39.25 - $50.42 $281,658 - $361,813	-7,176 Closed	0 $0
Q2 2021 Aug 04, 2021	BUY	$35.91 - $40.68 $257,690 - $291,919	7,176 New	7,176 $281,000
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $164,612 - $235,195	-6,090 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$32.92 - $37.36 $47,404 - $53,798	-1,440 Reduced 19.12%	6,090 $239,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $54,160 - $70,230	-1,667 Reduced 18.13%	7,530 $271,000
Q2 2019 Aug 08, 2019	BUY	$36.98 - $41.52 $108,980 - $122,359	2,947 Added 47.15%	9,197 $398,000
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $234,375 - $257,500	6,250 New	6,250 $265,000
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $212,679 - $257,967	-6,170 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $203,486 - $216,937	6,170 New	6,170 $224,000
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $185,109 - $214,753	-5,801 Closed	0 $0
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $168,162 - $178,426	-5,056 Reduced 46.57%	5,801 $210,000
Q3 2017 Nov 21, 2017	SELL	$31.0 - $34.15 $11.7 Million - $12.9 Million	-376,733 Reduced 97.2%	10,857 $388,000
Q3 2017 Nov 17, 2017	BUY	$31.0 - $34.15 $12 Million - $13.2 Million	387,590	387,590 $388,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$13.4 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.1 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.53 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.36 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.41 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Truepoint, Inc. with notifications on news.

Account